IM Cannabis Corp

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/23/2026

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeNASDAQ

Market Capitalization1.96 mln

Float1.45 mln

Earnings Date11/13/2026

Piotroski F-Score

2 / 9

Weak

Beneish M-Score

-5.81

Highly reliable

Relative Strength

2 / 100

Severely lagging

Pre-Tax Margin

-40%

Deeply loss-making

ROE

842

Extraordinary

Altman Z-Score

-16.12

Deeply distressed

Business Description

Founded in 2008 and based in Tel Aviv, IM Cannabis Corp. grows and distributes medical cannabis products across Israel and Germany. The company offers dried flowers and cannabis extracts through several established brands, including IMC, BLKMT, WAGNERS, and LOT420. All of its products are sold exclusively to medical patients.

Key Fundamentals

EPS-71.41

ROE842

RPS3.18

ROIC-35.30

ROA-54.13

Interest Cover-2.21

EBITDA, mln-8.04

EV / EBITDA-1.36

EV / EBIT-1.15

Revenue, mln33.12

EV / Revenue0.33

Quote Details

Last 0.8777

Change -0.047 (-5.08%)

Open 0.92

Volume 69,777

Turnover 61,243

Average Volume 232,934

Financial Ratios

Pre-Tax Profit Margin-40

Current Ratio0.56

Price / Sales0.01

Financial Strength

Altman Z-Score-16.12

Piotroski F-Score 2 / 9

Beneish M-Score-5.81

Short Ratio0.01

Short % of Float4.62

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-36.86%	1 / 100
1 Month	-72.4%	1 / 100
2 Months	-78%	2 / 100
6 Months	-89.7%	2 / 100
1 Year	-98.43%	2 / 100